Home › Funds › Bellevue Group AG › VERA
Bellevue Group AG position in VERA
VERA THERAPEUTICS INC · Health Care
Bellevue Group AG reported holding 1,710,808 shares of VERA (VERA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$73.4M, representing 1.54% of its reported portfolio and ranking #24 among its reported holdings. Bellevue Group AG has disclosed VERA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Bellevue Group AG's VERA position evolved
Bellevue Group AG first disclosed a stake in VERA in Q4 2025 at 1,698,152 shares (US$86.0M). Across 3 filings, Bellevue Group AG increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,710,808 shares valued at US$73.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.70M | $85.99M | New |
| Q1 2026 | 1.71M | $68.82M | Add |
| Q2 2026 | 1.71M | $73.41M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VERA and 13F data
VERA (VERA THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in VERA — the largest reported positions include Avoro Capital Advisors LLC (US$245.6M), Deep Track Capital, LP (US$171.6M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$168.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VERA
- Avoro Capital Advisors LLC 5.72M sh · $245.61M · Q2 2026
- Deep Track Capital, LP 4.00M sh · $171.64M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.92M sh · $168.05M · Q2 2026
- Kynam Capital Management, LP 2.89M sh · $124.01M · Q2 2026
- Sofinnova Investments, Inc. 2.79M sh · $119.89M · Q2 2026
- Eversept Partners, LP 2.21M sh · $94.95M · Q2 2026
- Logos Global Management LP 2.20M sh · $94.40M · Q2 2026
- Integral Health Asset Management, LLC 1.75M sh · $75.09M · Q2 2026
- GREAT POINT PARTNERS LLC 600.84K sh · $25.78M · Q2 2026
- BRAIDWELL LP 564.72K sh · $24.23M · Q2 2026
- Davern Capital Partners, LP 498.83K sh · $21.40M · Q2 2026
More on Bellevue Group AG
FAQ
How long has Bellevue Group AG held VERA?
Bellevue Group AG has disclosed VERA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Bellevue Group AG's current position in VERA?
As of Q2 2026, Bellevue Group AG holds 1.71M shares of VERA (VERA THERAPEUTICS INC), valued at $73.41M, representing 1.54% of its reported portfolio and ranking #24.
Has Bellevue Group AG been buying or selling VERA?
In the latest 13F filing (Q2 2026), Bellevue Group AG held unchanged its position in VERA.
Which other funds hold VERA?
Other major institutional holders of VERA include Avoro Capital Advisors LLC, Deep Track Capital, LP, DEERFIELD MANAGEMENT COMPANY, L.P., among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.